Jarisch-herxheimer reaction triggered by group B streptococcus intrapartum antibiotic prophylaxis.
July 29th, 2010Author: drugsCONCLUSION:: Beta-lactam antibiotics for group B Streptococcus intrapartum prophylaxis can trigger the Jarisch-Herxhemer reaction in patients with undiagnosed syphilis resulting in unanticipated changes in maternal and fetal well-being. PMID: 20664452 [PubMed - in process] (Source: Obstetrics and Gynecology)
|
 |
|
 |
|
||||||||||||||||||
Propylthiouracil-induced agranulocytosis in the third trimester of pregnancy.
July 29th, 2010Author: drugsCONCLUSION:: In circumstances in which thionamides are contraindicated, management options of hyperthyroidism in pregnancy are limited. The proximity to term in the third trimester makes expectant management an attractive approach when maternal thyroid indices are stable, allowing for a choice of postpartum therapies without the worry of fetal implications. However, this strategy carries risks, and thyroidectomy in the third trimester can be a safe alternative. PMID: 20664427 [PubMed - in process] (Source: Obstetrics and Gynecology)
|
|
|
|
|
||||||||||||||||||
Spontaneous Methicillin-Resistant Staphylococcus aureus Epidural Abscess in Pregnancy.
July 29th, 2010Author: drugsCONCLUSION:: Spontaneous epidural abscess is a rare condition and diagnosis is often delayed. The finding of Horner syndrome led to imaging of the cervical spine and diagnosis of epidural abscess. Early intervention resulted in resolution of neurologic symptoms and a successful pregnancy outcome. PMID: 20664432 [PubMed - in process] (Source: Obstetrics and Gynecology)
|
|
|
|
|
||||||||||||||||||
Primary psoas muscle abscess after an uncomplicated spontaneous vaginal delivery.
July 29th, 2010Author: drugsCONCLUSION:: Prompt recognition of and subsequent effective treatment for a psoas abscess are crucial to avoid potential long-term morbidity and even mortality. PMID: 20664424 [PubMed - in process] (Source: Obstetrics and Gynecology)
|
|
|
|
|
||||||||||||||||||
Primary iliopsoas abscess and pregnancy.
July 29th, 2010Author: drugsCONCLUSION:: Primary iliopsoas abscess should be considered in the differential diagnosis of low-back pain among high-risk pregnant women. Clinicians should be vigilant in identifying high-risk factors and aggressive in treating this rare and potentially fatal complication. PMID: 20664425 [PubMed - in process] (Source: Obstetrics and Gynecology)
|
|
|
|
|
||||||||||||||||||
New Health Policy: Encouraging Friendships?
July 29th, 2010Author: drugsHaving good social relationships – friends, marriage or children – may be every bit as important to a healthy lifespan as quitting smoking, losing weight or taking certain medications, U.S. researchers reported on Tuesday. Reuters Health Information (Source: Medscape Medical News Headlines)
|
|
|
|
|
||||||||||||||||||
Company Health Plans May Increasingly Demand Proof Family Is Family
July 29th, 2010Author: drugsCNNMoney: “Think your whole family is covered by your company health plan? Get ready to prove they’re actually your kin.” Under the new health overhaul law, starting next year “employers will have to provide coverage for dependents of employees [until] age 26. That will further inflate coverage costs for companies at a time when employers are already bracing for a 9% jump in their health care plan expenditures in 2011… (Source: Health News from Medical News Today)
|
|
|
|
|
||||||||||||||||||
Abbott’s SIMCOR(R) (Niacin Extended-Release / Simvastatin) Receives FDA Approval For New Dosage Strengths
July 29th, 2010Author: drugsAbbott received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCORî, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin – the most commonly prescribed dose of simvastatin – with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott’s proprietary niacin extended-release and simvastatin, the most commonly used statin. SIMCOR is a prescription medication used along with diet in people who cannot control their cholesterol levels by diet and exercise alone… (Source: Health News from Medical News Today)
|
|
|
|
|
||||||||||||||||||
e-Cigarette Aerosol Decreases Over Time In Smoke-Out Interval, Requiring Stronger Puffs
July 29th, 2010Author: drugsStronger suction is required to smoke “electronic cigarettes” – marketed as tobacco-free nicotine delivery systems – than conventional brands, with possible adverse effects on human health, researchers at the University of California, Riverside report. The researchers used a smoking machine to compare the smoking properties of eight conventional cigarettes with five e-cigarette brands. They examined the vacuum required to produce smoke (in the case of conventional cigarettes) or aerosol (in the case of e-cigarettes), and compared the density of the smoke/aerosol over time… (Source: Health News from Medical News Today)
|
|
|
|
|
||||||||||||||||||
Abbott’s SIMCOR î ( Niacin Extended-release / Simvastatin ) Receives FDA Approval For New Dosage Strengths
July 29th, 2010Author: drugsAbbott (NYSE: ABT) received U.S. Food and Drug Administration (FDA) approval for two new dosage strengths of SIMCORî, a cholesterol medication. The new SIMCOR dosage strengths combine 40 mg of simvastatin the most commonly prescribed dose of simvastatin with either 500 mg or 1,000 mg of niacin extended-release. SIMCOR is the first treatment to combine Abbott’s proprietary niacin extended-release and simvastatin, the most commonly used statin… (Source: Health News from Medical News Today)
|
|
|
|
|
||||||||||||||||||